Pregabalin Completed Phase 4 Trials for Central Neuropathic Pain Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT00313820Efficacy Of Pregabalin In Subjects With Post-Stroke Central Neuropathic Pain